7 results
Event
Biologics Price Competition and Innovation Act: Purple Book, Dispute Resolution, Exclusivities, and Court Treatment Biologics Price Competition and Innovation Act: Purple Book, Dispute Resolution, Exclusivities, and Court Treatment
January 5, 2023
Webinar
Event
Biologics Price Competition and Innovation Act: Purple Book, Dispute Resolution, Exclusivities, and Court Treatment Biologics Price Competition and Innovation Act: Purple Book, Dispute Resolution, Exclusivities, and Court Treatment
May 11, 2021
Webinar
IP Health Blog
Update to the Purple Book in Recent COVID-19 Stimulus Bill and Implications for BPCIA Litigation Update to the Purple Book in Recent COVID-19 Stimulus Bill and Implications for BPCIA Litigation
December 23, 2020
Conference
RAPS Regulatory Convergence RAPS Regulatory Convergence
September 21-24, 2019
Philadelphia
Event
Developing a Life Sciences Patent Portfolio Developing a Life Sciences Patent Portfolio
March 28, 2019
Webinar
IP Health Blog
FDA Draft Guidance on the BPCIA “Deemed to Be a License” Provision - Questions and Answers FDA Draft Guidance on the BPCIA “Deemed to Be a License” Provision - Questions and Answers
December 20, 2018
IP Health Blog
FDA Final Guidance on the BPCIA “Deemed to Be a License” Provision FDA Final Guidance on the BPCIA “Deemed to Be a License” Provision
December 20, 2018
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.